Gateway to the largest biotechnology sector in Australia

Find

Victorian Platform Technologies

Find Infrastructure

What's this

Victorian Biotech Companies & Providers

Advanced Search
What's this

R&D Tax Credit

R&D Tax Credit

Australia's new R&D Tax Credit makes Melbourne, Victoria one of the most attractive locations in the world for R&D.

The R&D Tax Credit replaces the R&D Tax Concession as Australia's principal initiative to support research and development. The new tax credit will apply to income years beginning on or after 1 July 2011.

Where a group’s annual turnover is less than $20 million, companies will be eligible for a 45% refundable credit, with no limit on the amount of expenditure claimable under this program. This is a significant increase from the existing limit of $5 million and the abolishment of a cap.

Where group turnover is over $20 million, companies will be eligible for a 40% non-refundable credit, equivalent to a 133% tax concession, one-third higher than the current basic rate of support.

Further, companies conducting R&D in Australia where intellectual property rights are held offshore (as for the current international premium R&D concession) will also be able to access this credit.

Links

Innovation Australia is an independent statutory body established to assist with the administration of the Australian Government's innovation and venture capital programs, including administration of the R&D Tax Credit.

What's Happening?

8th May BioBreakfast - The Technological and Economic Opportunities of BioBanking in Australia

Tuesday 8th May, 7:15am - 9:00am
Cinema 1, Australian Centre for the Moving Image (ACMI), Federation Square, Melbourne

As the pharmaceutical industry and the wider research sector shifts rapidly towards personalised medicine and genomics combined with the increasing power of computational sciences, biobanking is clearly an emerging winner in terms of commercialisation opportunity and provision of quality research services for the future.

More news and events